Sep 27, 2012 | Allgemein, company news @en, DE, transactions
The pharmaceutical arm of Covidien, Mallinckrodt has acquired CNS Therapeutics and its pipeline of pain and spasticity drug programmes for a reported $100 million. As it prepares to be spun out as a public company, St. Louis-based Mallinckrodt says that the buyout...
Sep 27, 2012 | Allgemein, company news @en, DE, transactions
The Canadian pharmaceutical company Valeant Pharmaceuticals International has assumed the rights to the medication Visudyne, which is used in age-related macular degeneration, from Canadian company QLT Inc.. For age-related macular degeneration, the centre of the...
Sep 25, 2012 | Allgemein, company news @en, DE, transactions
As part of the acquisition of Air Products Medical GmbH by Linde AG, legal regulations mean that the company is hence forth known as Linde Medical GmbH. The new name will come into effect on 1st October 2012. The company, however, remains independent with the...
Sep 24, 2012 | Allgemein, company news @en, DE, transactions
In the takeover battle for the hospital group Rhön-Klinikum, it appears that there could be another chapter: industry sources believe Munich-based rivals Sana Kliniken AG are working on an offer. Sana shareholders, who govern 31 private health insurance funds...
Sep 24, 2012 | Allgemein, company news @en, DE, transactions
Colby Pharmaceutical Company (San Jose), an American biopharmaceutical company has taken over Othera Pharmaceuticals Inc. (Conshohocken). Financial details of the transaction were not disclosed. With this acquisition, Colby has acquired an extensive portfolio of...
Sep 20, 2012 | Allgemein, company news @en, DE, transactions
Illumina Inc. of San Diego, USA has announced the acquisition of Cambridge-based Blue Gnome for an undisclosed fee. Now fully owned by Illumina, Blue Gnome provides solutions for the screening of genetic abnormalities associated with developmental delay, cancer and...